These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19947819)

  • 1. Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reports.
    Fraunfelder FW; Suhler EB; Fraunfelder FT
    Cutan Ocul Toxicol; 2010 Mar; 29(1):26-9. PubMed ID: 19947819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyarteritis nodosa reports to the vaccine adverse event reporting system (VAERS): implications for assessment of suspected vaccine-provoked vasculitis.
    Begier EM; Langford CA; Sneller MC; Wise RP; Ball R;
    J Rheumatol; 2004 Nov; 31(11):2181-8. PubMed ID: 15517631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diplopia and fluoroquinolones.
    Fraunfelder FW; Fraunfelder FT
    Ophthalmology; 2009 Sep; 116(9):1814-7. PubMed ID: 19643481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral uveitis associated with fluoroquinolone therapy.
    Hinkle DM; Dacey MS; Mandelcorn E; Kalyani P; Mauro J; Bates JH; Soukasian SH; Holland GN; Foster CS; Fraunfelder FT; Davis JL; Fraunfelder FW
    Cutan Ocul Toxicol; 2012 Jun; 31(2):111-6. PubMed ID: 21981449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
    Souayah N; Nasar A; Suri MF; Qureshi AI
    J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
    Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use.
    Fraunfelder FW; Richards AB
    Ophthalmology; 2008 Dec; 115(12):2282-5. PubMed ID: 18930555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination.
    Mikaeloff Y; Caridade G; Assi S; Tardieu M; Suissa S;
    Brain; 2007 Apr; 130(Pt 4):1105-10. PubMed ID: 17276994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.
    Chang S; Ball R; Braun MM
    Vaccine; 2008 May; 26(19):2428-32. PubMed ID: 18406499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
    Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
    J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS).
    DiMiceli L; Pool V; Kelso JM; Shadomy SV; Iskander J;
    Vaccine; 2006 Feb; 24(6):703-7. PubMed ID: 16154669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study.
    Yu O; Bohlke K; Hanson CA; Delaney K; Rees TG; Zavitkovsky A; Ray P; Mullooly J; Black SB; Benson P; Thompson WW; Davis RL; Jackson LA
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):736-45. PubMed ID: 17192842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B vaccination and adult associated gastrointestinal reactions: a follow-up analysis.
    Geier DA; Geier MR
    Hepatogastroenterology; 2002; 49(48):1571-5. PubMed ID: 12397738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
    Kurugöl Z; Mutlubaş F; Ozacar T
    Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum sickness and hepatitis B vaccine including review of the literature.
    Arkachaisri T
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S607-12. PubMed ID: 12403239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinations and risk of central nervous system demyelinating diseases in adults.
    DeStefano F; Verstraeten T; Jackson LA; Okoro CA; Benson P; Black SB; Shinefield HR; Mullooly JP; Likosky W; Chen RT;
    Arch Neurol; 2003 Apr; 60(4):504-9. PubMed ID: 12707063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B.
    Lo CM; Liu CL; Chan SC; Lau GK; Fan ST
    J Hepatol; 2005 Aug; 43(2):283-7. PubMed ID: 15964658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.